Breaking Business News: Crown Laboratories to Buy Revance Therapeutics in $924 Million Merger Deal
The Dermatology Digest
AUGUST 12, 2024
As a combined company, we have the opportunity to create a comprehensive portfolio of high-growth products for all stages of life, and we will be committed to investing in education, training, and practice support for aesthetics providers across the United States.” ” Mark J.
Let's personalize your content